Page last updated: 2024-10-31

milrinone and Alzheimer Disease

milrinone has been researched along with Alzheimer Disease in 1 studies

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Tariq, H1
Ahmed, B1
Hafiz, MY1

Other Studies

1 other study available for milrinone and Alzheimer Disease

ArticleYear
Milrinone: An advancement in the treatment of Alzheimer's disease.
    JPMA. The Journal of the Pakistan Medical Association, 2022, Volume: 72, Issue:6

    Topics: Alzheimer Disease; Cardiotonic Agents; Heart Failure; Humans; Milrinone; Pyridones

2022